COMPLETEDResults postedNA

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

This study expands upon pilot data for feasibility since May 2011. The study aims to evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in real-time on patient management decisions regarding the use of antimicrobial agents. Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus standard culture.

Sponsor

George Washington University

Enrollment

252 participants

Sites

2 locations

Start Date

May 2011

Completion

January 2015

Cutaneous AbscessXpert MRSA/SA SSTIStandard culture

Enrollment & Timeline

Completed

Target N

252

participants

Sites

locations

Duration

3.7 years

total trial span

Rate

pts/month needed

At 2 sites, each site needs to enroll approximately 3.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of Participants With Antibiotic Usage at the Time of the ED Visit

Baseline

Number of Participants with Antibiotic Usage at the time of the ED visit (narrow spectrum, broad spectrum, or none) will be recorded at the time of the ED visit

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

May Larissa S, Rothman Richard E, Miller Loren G et al.Infection control and hospital epidemiology2016

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

COMPLETEDResults postedNA

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

Sponsor

George Washington University

Enrollment

252 participants

Sites

2 locations

Start Date

May 2011

Completion

January 2015

Cutaneous AbscessXpert MRSA/SA SSTIStandard culture

Enrollment & Timeline

Completed

Target N

252

participants

Sites

locations

Duration

3.7 years

total trial span

Rate

pts/month needed

At 2 sites, each site needs to enroll approximately 3.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of Participants With Antibiotic Usage at the Time of the ED Visit

Baseline

Number of Participants with Antibiotic Usage at the time of the ED visit (narrow spectrum, broad spectrum, or none) will be recorded at the time of the ED visit

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

May Larissa S, Rothman Richard E, Miller Loren G et al.Infection control and hospital epidemiology2016

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (2)